Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 14;7(1):135-149.
doi: 10.3233/ADR-220103. eCollection 2023.

Barriers to Using Legally Authorized Representatives in Clinical Research with Older Adults

Jessica Mozersky  1 , Erin D Solomon  1 , Kari Baldwin  1 , Matthew Wroblewski  1 , Meredith Parsons  1 , Melody Goodman  2 , James M DuBois  1
Affiliations

Barriers to Using Legally Authorized Representatives in Clinical Research with Older Adults

Jessica Mozersky et al. J Alzheimers Dis Rep. .

Abstract

Background: Older adults are at increased risk of cognitive impairments including Alzheimer's disease dementia. Legally authorized representatives (LARs) can provide informed consent when a participant is no longer able to, but little is known about barriers to incorporating them in research.

Objective: Explore reasons for not asking and documenting participant decisions to appoint LARs among researchers conducting clinical intervention trials studying older adults or individuals with cognitive impairments.

Methods: Mixed method design consisting of a survey (N = 1,284) and qualitative interviews (N = 40) regarding barriers to incorporating LARs. Participants were principal investigators and clinical research coordinators.

Results: 37% (N = 469) had not asked and documented participant decisions about appointing LARs in the prior year. They had significantly lower confidence in resources available to incorporate LARs and lower positive attitudes compared to their counterparts who had done so. The majority (83%) had no trials studying individuals with cognitive impairments and reported LARs were not applicable. A minority (17%) had at least one trial studying individuals with cognitive impairments and reported being unaware of LARs. Qualitative findings indicate discomfort broaching a sensitive topic especially with individuals who are not yet impaired.

Conclusion: Resources and education to increase awareness and knowledge of LARs are needed. Researchers studying older adults should, at minimum, have the knowledge and resources to incorporate LARs when necessary. Stigma and discomfort discussing LARs will need to be overcome, as early proactive discussions before a participant loses decisional capacity could enhance participant autonomy and facilitate recruitment and retention of older adults to research.

Keywords: Clinical research; cognitive impairments; informed consent; legally authorized representatives; older adults; proxy; research ethics; surrogate.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interest to report.

References

    1. National Institutes of Health (2019) Inclusion Across the Lifespan, https://grants.nih.gov/policy/inclusion/lifespan.htm, Accessed July 9, 2022.
    1. Bernard MA, Clayton JA, Lauer MS (2018) Inclusion across the lifespan: NIH Policy for Clinical Research. JAMA 320, 1535–1536. - PubMed
    1. Boss L, Branson S, Pickens S (2017) Ethical issues in geriatric research. In Ethical Considerations and Challenges in Geriatrics, Catic AG, ed. Springer International Publishing, Cham, pp. 157–167.
    1. National Institutes of Health (2018) Inclusion Across the Lifespan Executive Summary. https://grants.nih.gov/sites/default/files/IAL-II-Workshop-Report.pdf
    1. Plassman BL, Langa KM, Fisher GG, Heeringa SG, Weir DR, Ofstedal MB, Burke JR, Hurd MD, Potter GG, Rodgers WL, Steffens DC, McArdle JJ, Willis RJ, Wallace RB (2008) Prevalence of cognitive impairment without dementia in the United States. Ann Intern Med 148, 427–434. - PMC - PubMed

LinkOut - more resources